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ABSTRACT  24 
Aim: To validate an optimised Peptide-mediated magnetic separation (PMS)-Phage 25 
assay for detection of viable Mycobacterium avium subsp. paratuberculosis (MAP) in 26 
milk. 27 
Methods and Results: Inclusivity, specificity and limit of detection 50% (LOD50) of 28 
the optimised PMS-phage assay were assessed. Plaques were obtained for all 43 29 
MAP strains tested. Of 12 other Mycobacterium spp. tested, only M. bovis BCG 30 
produced small numbers of plaques.  LOD50 of the PMS-phage assay was 0.93 MAP 31 
cells per 50 ml milk, which was better than both PMS-qPCR and PMS-culture. When 32 
individual milks (n=146) and bulk tank milk (BTM, n=22) obtained from Johne’s 33 
affected herds were tested by the PMS-phage assay, viable MAP were detected in 34 
31 (21.2%) of 146 individual milks and 13 (59.1%) of 22 BTM, with MAP numbers 35 
detected ranging from 6-948 PFU per 50 ml milk. PMS-qPCR and PMS-MGIT culture 36 
proved to be less sensitive tests than the PMS-phage assay.  37 
Conclusions: The optimised PMS-phage assay is the most sensitive and specific 38 
method available for the detection of viable MAP in milk. Further work is needed to 39 
streamline the PMS-phage assay, because the assay’s multi-step format currently 40 
makes it unsuitable for adoption by the dairy industry as a screening test.  41 
Significance and Impact of the study: The inclusivity (ability to detect all MAP 42 
strains), specificity (ability to detect only MAP), and detection sensitivity (ability to 43 
detect low numbers of MAP) of the optimised PMS-phage assay have been 44 
comprehensively demonstrated for the first time.   45 
 46 
Keywords:  Mycobacterium avium subsp. paratuberculosis (MAP), PMS-phage 47 
assay, detection sensitivity, detection specificity, milk testing 48 
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Introduction 49 
 50 
Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 51 
Johne's disease (JD), a chronic enteric wasting disease primarily affecting domestic 52 
ruminants (Stabel 1998; Sweeney 2011). Infected animals shed the pathogen in their 53 
faeces and milk. JD is found throughout the world and many different estimates of 54 
herd prevalence have been reported (Manning and Collins 2001; Tiwari et al. 2006; 55 
Wilson et al. 2010). However, the true prevalence of JD among farmed animals is 56 
unknown and, because of limitations of current methodologies for the detection of 57 
MAP, levels of MAP infection reported are likely to be underestimates in many 58 
cases. A study carried out by Nielsen and Toft (2009) reviewed many prevalence 59 
studies carried out across Europe and concluded that the prevalence of JD is likely 60 
to be >50% in many European countries.   61 
 There is some evidence to suggest an association between MAP and various 62 
chronic long-term human disorders, including Crohn's disease (CD), irritable bowel 63 
syndrome, Type 1 diabetes (T1DM), Multiple Sclerosis (MS), and more recently HIV 64 
infection, sarcoidosis, and Hashimoto Thyroiditis (Waddel et al. 2015). Although the 65 
role of MAP in the development, or progression, of any of these human diseases is 66 
still unclear, recent meta-analysis studies demonstrated a significant association with 67 
at least three of these human disorders including CD (Feller et al. 2007; Waddel et 68 
al. 2015; Timms et al. 2016), T1DM and MS (Waddel et al. 2015).  Uncertainty about 69 
the role of MAP as a human pathogen still remains, and there is general consensus 70 
within the food safety community that human exposure to MAP should be minimized 71 
as a precautionary measure. Consumption of milk, and possibly meat, from infected 72 
animals is currently viewed as a potential source of zoonotic transmission of the 73 
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pathogen from animals to humans. MAP has been isolated from retail milk and dairy 74 
products in many parts of the world (Grant et al. 2002; Ayele et al. 2005; Ellingson et 75 
al. 2005; Carvalho et al. 2012; Paolicchi et al. 2012) suggesting that the pathogen 76 
can enter the human food chain and that current High Temperature, Short Time 77 
(HTST) pasteurization may not always ensure complete inactivation of this 78 
pathogenic bacterium.  79 
 Traditional cultural methods cannot be routinely adopted to demonstrate the 80 
presence of viable MAP in milk because the methods are time-consuming, not 81 
specific and lack sensitivity (Slana et al. 2008a). Indeed, chemical decontamination 82 
applied before culture to inactivate the competitive flora has been proven to have a 83 
detrimental effect on the viability of MAP (Grant et al. 2003; Gao et al. 2005), and 84 
also to extend the time required for primary isolation. A number of molecular tests 85 
including both conventional and quantitative PCR methods have been successfully 86 
developed to permit faster detection of MAP in milk (Timms et al. 2011). However, 87 
most of these tests do not provide information about the viability of detected cells 88 
and their sensitivity is generally affected by non-mycobacterial DNA, protein and 89 
PCR inhibitors present in test samples, unless laborious DNA extraction methods are 90 
applied before DNA amplification (Timms et al. 2015). 91 
 We recently combined an optimized phage amplification assay (Foddai et al. 92 
2009) with selective peptide-mediated magnetic separation (PMS) (Foddai et al. 93 
2010b) to achieve a rapid novel detection test for viable MAP.  The PMS-phage 94 
method exploits the use of D29 mycobacteriophage and is able to provide rapid 95 
enumeration of viable MAP in milk and veterinary samples within 48 h (Foddai et al. 96 
2011), based on the number of plaques (lysis areas) produced on a lawn of fast-97 
growing M. smegmatis. More recently, an optimized milk sample preparation protocol 98 
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to maximize accuracy of MAP counts when testing cows’ milk was described (Foddai 99 
and Grant 2015).  The aims of the present study were: (1) to assess inclusivity and 100 
specificity of the recently optimised PMS-phage assay by testing a large number of 101 
MAP strains and other bacterial milk isolates; (2) to compare the limit of detection 102 
50% (LOD50) of the optimised PMS-phage assay with those of PMS-culture and 103 
PMS-qPCR targeting both IS900 and f57 by testing artificially contaminated milk 104 
samples; and (3) to test individual raw milk samples and bulk tank milk from dairy 105 
herds affected by JD to assess the applicability of the optimised PMS-phage assay 106 
for raw milk testing.  107 
 108 
Materials and methods 109 
 110 
Bacterial strains and growth conditions 111 
Forty-three MAP strains (three type strains and 40 cattle, raw and pasteurised cow’s 112 
milk, untreated water, or Crohn’s disease isolates, acquired or isolated over the past 113 
20 years and available within the Queen’s University Belfast (QUB) culture 114 
collection), 12 other Mycobacterium spp. (Table 1), and five bacterial isolates (one 115 
Gram positive coccus and four Gram positive rods) obtained by plating a sample of 116 
raw cows’ milk on Nutrient agar (Oxoid Ltd., Basingstoke, UK), were used in this 117 
study. All MAP strains were grown in a shaker incubator for 4-6 weeks at 37ºC to 118 
stationary phase in Middlebrook 7H9 broth containing 10% (v/v) OADC supplement 119 
(both from Difco) and 2 µg per ml mycobactin J (Synbiotics Europe SAS, Lyon, 120 
France). All Mycobacterium spp. were cultivated at appropriate temperatures 121 
(dependent on species) to stationary phase (between 3 and 15 days) in the same 122 
6 
 
7H9 medium without the addition of mycobactin J. Milk isolates were grown 123 
overnight in 10 ml of nutrient broth at 25°C.  124 
 125 
Peptide-mediated magnetic separation (PMS) 126 
PMS was performed on 1 ml of sample using 5 µL biotinylated-aMp3 peptide- and 5 127 
µL biotinylated-aMptD peptide-coated MyOneTM Tosylactivated Dynabeads® (Life 128 
Technologies), prepared in-house as previously described (Foddai et al. 2010b). 129 
Magnetic separation was carried out using the Dynal BeadRetriever (Life 130 
Technologies). Magnetic capture was carried out for 30 min at room temperature 131 
under continuous mixing, followed by two washes in 1 ml Phosphate buffered saline 132 
(PBS) containing 0.05% (v/v) Tween 20 (PBS-T20, Sigma), and final resuspension of 133 
the beads in 1 ml 7H9 broth containing 10% (v/v) OADC. 134 
 135 
Optimised phage amplification assay 136 
The optimised phage assay was carried out as previously described by Foddai et al. 137 
(2009). Briefly, after overnight incubation of samples at 37oC in 1 ml of 7H9 medium 138 
containing 2 mmol l-1 CaCl2, samples were incubated for 2 hours at 37ºC with 108 139 
D29 mycobacteriophage before  treatment with 100 mmol l-1 ferrous ammonium 140 
sulphate (FAS, Sigma) for 10 min at room temperature to inactivate any 141 
exogenous/non-adsorbed seed phage. Samples were then mixed with 5 ml 7H9 142 
medium containing 2 mmol l-1 CaCl2 and returned to the incubator at 37oC for a 143 
further 90 min before being plated with tempered 7H9 agar and 1 ml Mycobacterium 144 
smegmatis mc2 155 (108 CFU per ml). Plaques were counted following overnight 145 
incubation of plates at 37oC. 146 
 147 
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Confirmation of inclusivity of the novel PMS-phage assay by testing a broad 148 
range of MAP strains 149 
Before being tested by the optimised PMS-phage assay, all stationary MAP broth 150 
cultures were declumped by ultrasonication applied as previously described (Foddai 151 
and Grant 2015) at 37 kHz for 4 min on ice in a Ultrasonic PH 30 (Fisher Scientific 152 
Ltd) and then tested for purity (presence of only red acid-fast cells) by Ziehl–Neelsen 153 
(ZN) staining. The number of cells per ml of broth was estimated by measuring the 154 
optical density at 600nm (OD600) using a WPA CO8000 cell density meter (SISLAB, 155 
Italy). For each sample, optical density was adjusted to an OD600 of 0.1 156 
(approximately 106-107 MAP cells per ml) followed by serial dilution of cultures in 157 
PBS-T20. PBS-T20 suspensions containing approximately 102-103 MAP per ml were 158 
finally processed through optimised PMS-phage assay to assess inclusivity of the 159 
assay. The number of MAP cells detected was indicated by plaques (zones of 160 
clearing) produced on agar plates containing 5 ml of molten 7H9 agar and 1 ml of M. 161 
smegmatis mc2 155, and reported as plaque-forming-units (PFU) per ml. The 162 
experiment was repeated twice for each of the 43 MAP strains. 163 
 164 
Confirmation of specificity of the D29-based phage assay by testing various 165 
environmental Mycobacterium spp. and non-mycobacterial raw milk isolates 166 
Broth suspensions of 12 environmental Mycobacterium spp. and five raw milk 167 
isolates spiked at three levels (10-102, 102-103, 103-104 cells per ml) were processed 168 
through the phage assay to assess specificity of the assay for MAP. For each 169 
sample tested, inoculum was prepared as described above. Number of bacterial 170 
cells per ml stationary phase broth was estimated by measuring and adjusting the 171 
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original optical density followed by serial dilution of samples in 1 ml PBS-T20. The 172 
experiment was repeated twice for each Mycobacterium sp. and raw milk isolate. 173 
 174 
Comparison of the limit of detection 50% (LOD50) of the PMS-phage assay, 175 
PMS-culture and PMS-qPCR 176 
Ultra-high temperature (UHT) milk purchased from a local supermarket and 177 
artificially contaminated at different levels with MAP was used to compare the LOD50 178 
of the three detection methods. Three sets of 50 ml UHT milk samples were spiked 179 
in triplicate at four levels of MAP contamination (target final concentrations 102-103, 180 
10-102, 1-10 and 0 PFU per 50 ml) by adding 1 ml of an appropriate dilution of MAP 181 
NCTC 8578 or ATCC 19698 per 50 ml of milk. The number of MAP added at the 182 
highest spiking level, in each case, was determined by the optimised phage 183 
amplification assay (no PMS) applied to the diluted MAP culture used as inoculum. 184 
Each set of 50 ml milk samples was processed through PMS followed by either the 185 
phage amplification assay, culture or qPCR. Irrespective of detection method, milk 186 
sample preparation included: (i) centrifugation at 2,500 x g for 15 min, (ii) declumping 187 
by ultrasonication applied to the resuspended pellet fraction (Foddai and Grant, 188 
2015), (iii) PMS, and then one of the following detection methods: 189 
a) Phage assay applied after a previous overnight incubation of bead samples in 190 
7H9 Middlebrook broth supplemented with 10% (v/v) OADC, 2 mmol l-1 CaCl2 and 191 
NOA Antimicrobial Supplement (Product code 3A201N-300, Abtek Biological Ltd, 192 
Liverpool UK; final concentrations per ml of broth: Nystatin 50 IU, Oxacillin 2 µg, 193 
Aztreonam 30 µg); 194 
b)  Culture on plates of Herrold’s egg yolk medium (HEYM) supplemented with  2 µg 195 
per ml mycobactin J and PANTA (Becton Dickinson;  final concentrations per ml of 196 
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HEYM: 10 IU Polymyxin B, 1 μg Amphotericin, 4 μg Nalidixic acid, 1 μg Trimethoprim 197 
and 1 μg Azlocillin);  198 
c)  qPCR targeting both IS900 and f57 (Donaghy et al. 2010) applied on MAP DNA 199 
released from captured cells through heating samples at 95°C for 25 min. All qPCR 200 
reactions were performed on an EcoTM Real-Time PCR system (Illumina, Inc). 201 
 The limit of detection experiment was carried out with two MAP type strains, 202 
ATCC 19698 and NCTC 8578.  203 
 204 
Testing of individual and bulk tank milks from Johne’s affected herds  205 
A total of 146 individual raw milk samples and three bulk tank milks (BTM) sourced 206 
from a large JD affected dairy herd in southern England, identified with the help of Mr 207 
Peter Orpin (Park Veterinary Group, Leicester), and 19 BTM obtained from dairy 208 
herds in Scotland with the help of Dr George Caldow (SAC Consulting Services, St 209 
Boswells) were tested for MAP. The individual milk samples were collected by farm 210 
workers during one morning milking session into sterile 50 ml centrifuge tubes 211 
supplied by QUB. Milk samples were immediately frozen and stored overnight on 212 
farm before being transported to QUB in insulated boxes by an overnight courier. 213 
Samples arrived at QUB in a partially frozen state and were immediately placed in -214 
80oC freezer.  Before application of the PMS-phage assay sample preparation 215 
included: thawing overnight in the refrigerator at 4oC, room temperature for 1 h 216 
before centrifugation of 50 ml milk at 2500 x g for 15 min at room temperature, 217 
resuspension of milk pellet fraction in 1 ml PBS-T20, application of ultrasonication to 218 
disperse MAP clumps (Foddai and Grant 2015), and then PMS. After PMS, samples 219 
were concentrated in a final volume of 150 µl of sterile RNAse/DNAse free water 220 
(Sigma) and divided into three aliquots (50 µl) to be processed via the three different 221 
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detection methods - phage amplification assay, culture, and real time qPCR as 222 
described below. 223 
 224 
Phage amplification assay and confirmatory Plaque PCR 225 
Following overnight incubation of the bead samples at 37oC in a final volume of 1 ml 226 
7H9 medium supplemented with 10% (v/v) OADC, 2 mmol l-1 CaCl2 and NOA 227 
Antimicrobial Supplement (as described above), the phage amplification assay was 228 
carried out as described by Foddai et al. (2009). After overnight incubation, plaques 229 
(1 to, maximum, 10 depending on PFU counts) from positive phage assay plates 230 
were harvested and processed through DNA extraction as described by Swift et al. 231 
(2013). Plaque DNA in each aliquot was concentrated and purified through 232 
ZymocleanTM Gel DNA Recovery Kit (Zymo Research, Irvine, Ca, USA), and then 233 
subjected to IS900 Plaque-PCR as described by Stanley et al. (2007). 234 
 235 
Culture and confirmation of MAP isolation 236 
After PMS, samples were cultivated in BD BBL MGIT™ Mycobacteria Growth 237 
Indicator Tubes containing 4 ml of modified Middlebrook liquid broth enriched with 238 
0.5 ml BBL™ MGIT™ OADC and 0.1 ml MGIT™ PANTA™ antibiotic mixture (all 239 
Becton Dickinson Limited, USA). Cultures were incubated for 16-20 weeks at 37ºC 240 
and were periodically monitored using a BACTEC MicroMGIT reader (Becton 241 
Dickinson Limited, USA). Liquid broths showing evidence of growth were tested by 242 
ZN staining for the presence acid-fast bacilli and by IS900 PCR (Naser et al. 2013) 243 
to identify MAP positive cultures.  All cultures that tested acid-fast and IS900 PCR 244 
positive were then subjected to a mild chemical decontamination treatment in 0.75% 245 
(w/v) hexadecylpyridinium chloride (HPC) for 60 min at room temperature before 246 
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being sub-cultured onto Herrold’s egg yolk agar (HEYM) slopes supplemented with 247 
mycobactin J and PANTA. Slopes were incubated at 37°C for over 10 months to 248 
achieve isolation of typical colonies and final identification as MAP. 249 
 250 
Real time qPCR 251 
Each sample analysed by real time qPCR targeting IS900 and f57 MAP sequences 252 
(Donaghy et al. 2010) was tested in duplicate. DNA was released from PMS samples 253 
by heating samples at 95°C for 25 min. After brief centrifugation at 10,000 g for 1 min 254 
to sediment beads, an aliquot of 2.5 µl of the supernatant was used per qPCR 255 
reaction. Each qPCR reaction was performed in a final volume of 25 µl including: 256 
TaqMan Universal 2X PCR master mix (Applied Biosystems), EXO IPC 10x mix and 257 
EXO IPC 10x DNA (Applied Biosystems), 10 µmol l-1 of each forward and reverse 258 
primer, 5 µmol l-1 of specific probe (Donaghy et al. 2010), and 2.5 µl template DNA. 259 
PCR was performed using an EcoTM Real-Time PCR system (Illumina, Inc) with the 260 
following thermal cycling conditions: 50°C for 2 min; 95°C for 10 min, and 40 cycles 261 
of 95°C for 15 s and 60°C for 1 min. 262 
 263 
Statistical analysis of results 264 
For inclusivity and specificity testing, positive or negative results for the plaque assay 265 
applied after PMS were used as a final result. Limit of detection (LOD50) and 266 
associated 95% confidence limits of the three methods assays (PMS-phage assay, 267 
PMS-culture, PMS-IS900 and f57 qPCR) were estimated using the generalized 268 
Spearman-Karber LOD50 calculation for 4-level spiking protocols (AOAC 269 
International 2006). Kappa agreement between test results was determined using 270 
EpiTools Epidemiological Calculators (http://epitools.ausvet.com.au).  271 
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 272 
Results 273 
 274 
Confirmation of inclusivity of the novel PMS-phage assay  275 
All 43 MAP strains tested by the PMS-phage assay yielded plaques, confirming 276 
100% inclusivity of the test (Figure 1). PFU counts observed for most of the MAP 277 
strains (40 of 43, 93%) ranged from 100 to 300 (mean 142.26±51.97 PFU per ml); 278 
the number of plaques expected based on the culture dilution tested. Three MAP 279 
strains (NCTC 8578, 307R and Van Veen 52991-1) showed greater variability in 280 
counts between replicates and a higher mean PFU ml-1 count (mean 681.50±165.91 281 
PFU per ml) than was observed for the other strains tested (Figure 1).  282 
 283 
Confirmation of specificityof the PMS-phage assay  284 
 Eleven of the 12 non-target Mycobacterium spp. tested negative by the PMS-phage 285 
assay (i.e. no plaques observed), as did all five raw milk bacterial isolates tested. 286 
Some plaques were observed for M. bovis BCG at the highest spiking level (103-104 287 
CFU per ml) tested only, however the number of plaques (6.5 and 10.5 PFU per ml) 288 
after PMS was substantially lower than the original spiked population (data not 289 
shown). The mean percentage non-specific recovery of M. bovis BCG observed in 290 
two separate experiments was 0.19±0.08%.   291 
 292 
Comparison of the LOD50 of the PMS-phage assay, PMS-culture and PMS-293 
qPCR 294 
Before testing by the three methods, spiked UHT milk samples contained 920, 92 295 
and 9 PFU per 50 ml of MAP ATCC 19698, and 860, 86 and 8 PFU per 50 ml milk of 296 
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MAP NCTC 8578; determined by the optimised phage amplification assay (without 297 
PMS).  Higher detection sensitivity for MAP was exhibited by the PMS-phage assay 298 
compared to the PMS-qPCR and PMS-culture assays applied in parallel to spiked 299 
milk samples. The LOD50 of the PMS-phage assay was estimated to be 0.90 and 300 
0.95 PFU per 50 ml milk (calculation of 95% CI not possible) for MAP strains NCTC 301 
8578 and ATCC 19698, respectively (Table 2). PMS-IS900 qPCR had the next 302 
highest detection sensitivity, followed by PMS-f57 qPCR, and finally PMS- culture. 303 
The LOD50 of PMS-IS900 qPCR was 136.7 (95% CI: 21.4-872.9) and 134.55 (95% 304 
CI: 23.45-772.80) MAP cells per 50 ml milk for strains NCTC 8578 and ATCC 19698, 305 
respectively; the LOD50 of f57 qPCR was 303.7 and 291.00 MAP cells per 50 ml milk 306 
(calculaton of 95% CI not possible) for strains NCTC 8578 and MAP ATCC19698, 307 
respectively (Table 2). An LOD50 for PMS-culture could not be calculated because 308 
none of the milk samples spiked at the highest level (102-103 CFU per 50 ml) yielded 309 
colonies on HEYM agar plates, and thus use of the Excel LOD50 calculator (AOAC 310 
International, 2006) was not valid.   311 
 312 
Testing of individual and bulk tank milks from Johne’s affected herds  313 
Table 3 summarises the number and percentage of individual and bulk tank milk 314 
samples testing MAP positive by the three detection methods. Overall, 59 milk 315 
samples yielded plaques in the PMS-phage assay, some or all of which (depending 316 
on numbers present) were harvested and subjected to IS900 Plaque-PCR.  Of the 317 
59 plaque composites tested by IS900 Plaque-PCR, 44 (31 from individual milks and 318 
13 from BTM, 74.6%) yielded clear, positive IS900 Plaque-PCR results, 5 (8.5%) 319 
yielded inconclusive PCR results, 10 (16.9%) yielded negative PCR results, and one 320 
was not tested because plaques had merged and individual plaques could not be 321 
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harvested. Therefore, viable MAP were confirmed to be present in 31 (21.2 %) of 322 
146 individual milks and 13 (59.1%) of 22 BTM tested by the PMS-phage assay 323 
(Table 3). Mean viable MAP counts indicated by the PMS-phage assay in the 324 
positive individual raw milks and bulk tank milks were 228.1 PFU per 50 ml (range 6-325 
948 PFU per 50 ml) and 136.83 PFU per 50 ml (range 18-685 PFU per 50 ml), 326 
respectively.  327 
 Due to budget restrictions, and the relatively high cost of qPCR testing, real 328 
time qPCR was only used to test all 22 bulk tank milks and selected individual raw 329 
milk samples (n=77, 47 samples that had tested PMS-phage assay positive and 30 330 
other randomly selected samples that had tested PMS-phage assay negative).  This 331 
may have biased the outcome of the PMS-qPCR tests, so direct comparisons with 332 
the outcomes of the PMS-phage assay and PMS-culture will not be made. MAP was 333 
detected by qPCR in 7 (9.1%) out of 77 individual raw milk samples and 10 (45.4%) 334 
out of 22 BTM tested. IS900 qPCR showed higher detection rates than f57 qPCR, as 335 
expected. Of the seven individual raw milks that tested qPCR positive, all 7 (9.1%) 336 
tested IS900 qPCR positive and 2 samples (2.6%) tested both IS900 and f57 qPCR 337 
positive. Of the 10 BTM that tested qPCR positive, 10 (45.4%) tested IS900 qPCR 338 
positive, only 2 (9.1%) tested both IS900 and f57 qPCR positive.   339 
 When cultured in MGIT broth (not HEYM agar plates, as in first part of the 340 
study) after PMS, 49 (33.6%) of the 146 individual raw milk cultures and 16 (72.7%) 341 
of the 22 BTM cultures showed evidence of acid-fast bacteria when tested by ZN 342 
staining; many of these cultures were mixed cultures and showed evidence of the 343 
presence of non-acid-fast bacteria. Isolation of MAP cells was confirmed in 17 344 
(11.6%) individual raw milk and 11 (50%) BTM cultures by IS900 PCR (Naser et al. 345 
2013).  Inter-relationships between results of the PMS-phage assay, PMS-culture 346 
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and PMS-qPCR applied to individual raw milks and BTM are shown as Venn 347 
diagrams in Figure 2.  It should be noted in the case of the individual raw milks, 9 of 348 
the 17 milk samples that tested PMS-culture positive (Figure 2A) and 2 of the 7 milk 349 
samples that tested PMS-qPCR positive (Figure 2B) also yielded plaques with the 350 
PMS-phage assay; however the presence of MAP DNA in the plaques harvested 351 
was either not confirmed by Plaque-PCR or the plaque-PCR result was inconclusive, 352 
and so a PMS-phage assay negative result was recorded. Two BTM samples tested 353 
PMS-phage assay negative but PMS-culture, and PMS-culture and qPCR positive 354 
(Figure 2C). It is possible that overgrowth of environmental mycobacteria adhering to 355 
the peptide-coated magnetic beads going into the phage assay may have masked 356 
plaques in the M. smegmatis lawns for these samples.  As no plaques were 357 
observed, these two samples were recorded as PMS-phage assay negative as a 358 
result, when potentially this was a false negative result.    359 
 Overall, agreement between results of the PMS-phage assay and those of 360 
PMS-culture and PMS-qPCR tests was ‘fair ’ and  “poor”, respectively, when 146 361 
individual milks were tested (PMS-phage v PMS-culture: Kappa 0.25, 95% CI: 0.062 362 
to 0.439, P=0.0028; PMS-phage v PMS-IS900 qPCR: Kappa 0.073, 95% CI: -0.084 363 
to 0.231, P=0.1695), whereas it was  ‘moderate’ in both cases when 22 BTMs were 364 
tested (PMS-phage v PMS-culture: Kappa 0.538, 95% CI: 0.184 to 0.892, P=0.0056; 365 
PMS-phage v PMS-IS900 qPCR: Kappa 0.553, 95% CI: 0.220 to 0.885, P=0.0036).   366 
 367 
Discussion 368 
Culture is still generally considered the ‘gold standard’ method to demonstrate the 369 
presence of viable MAP in test samples. However, the method is time consuming,  370 
takes weeks to yield results, and any MAP counts obtained are going to be 371 
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underestimates due to the inclusion of a chemical decontamination step prior to 372 
culture which can adversely impact MAP viability. There is interest amongst dairy 373 
producers and processors to identify a rapid method that could be adopted to detect 374 
the presence of MAP in raw milk from primary suppliers and dairy products produced 375 
from this milk. The aim of this study was to evaluate the performance of an already 376 
described PMS-phage assay (Foddai et al. 2011) for the rapid detection of viable 377 
MAP in cows’ milk that has undergone further optimisation over recent years (Foddai 378 
and Grant, 2015). The method exploits the ability of D29 mycobacteriophage to 379 
replicate and amplify within only viable mycobacterial cells and represents an 380 
optimized version (Foddai et al. 2009; Foddai et al. 2010a) of the commercially 381 
phage-based test (FASTPlaqueTBTM assay, Biotec Laboratories Limited, Ipswich), 382 
which was originally developed for the rapid detection of viable M. tuberculosis.   In 383 
order to maximize specificity of detection, the phage amplification assay is applied 384 
after selective capture of MAP cells on paramagnetic beads coated with two 385 
selective anti-MAP peptide binders (Foddai et al. 2010b). To date, only results of 386 
PMS-phage assay testing of a limited number of naturally contaminated BTM (n=44) 387 
and faeces (n=39) samples have been reported, providing proof-of-concept for the 388 
PMS-phage assay (Foddai et al. 2011).  Further refinements to the milk testing 389 
procedure, mostly related to optimising milk sample preparation prior to PMS, have 390 
been made since 2011. Therefore, this study was carried out to assess inclusivity, 391 
specificity and detection sensitivity of an optimised version of the PMS-phage assay, 392 
and to compare this assay with PMS-culture and PMS-qPCR. 393 
Inclusivity of a microbiological test is the ability to detect the target 394 
microorganism within a wide range of bacterial strains. Prior to this study a limited 395 
range of MAP strains had been tested by PMS and also by the phage amplification 396 
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assay (Foddai et al. 2009; Foddai et al. 2010a, 2010b). A much broader range of 397 
MAP strains (n= 43) isolated from various sources (animals, milk, water and 398 
humans) was tested as part of this study to demonstrate inclusivity for MAP of the 399 
two peptide binders aMp3 and aMptD involved in the PMS, and of the D29 400 
mycobacteriophage involved in the phage amplification assay. The observation of 401 
plaques when the MAP strains were tested demonstrated that all strains were 402 
successfully infected by D29 mycobacteriophage, and this finding confirmed 100% 403 
inclusivity for MAP. Although some variability in PFU counts was observed, similar 404 
plaque counts were observed for the vast majority (93%) of MAP strains tested.  This 405 
also suggests that consistent capture was being achieved by the two peptide binders 406 
during PMS. Due to the hydrophobic nature of its cell wall, MAP cells tend to 407 
aggregate in clumps, the presence of which impacts accurate enumeration of viable 408 
MAP cells in tested samples. The appearance of the MAP broths before testing 409 
visibly differed between strains, likely due to variations in clump size and distribution, 410 
and even after de-clumping some broths still showed visible clumps that had not 411 
been fully dispersed. These observations might explain the variability in PFU counts 412 
observed for different MAP cultures, and lower PFU counts may have resulted due to 413 
counting of clumps of cells rather than just single cells. Conversely, MAP cultures 414 
that contained larger clumps that were effectively dispersed into single cells by 415 
ultrasonication treatment would yield higher PFU counts; which was apparently the 416 
case for MAP strains NCTC 8578, 307R and Van Veen 52991-1.  In the case of MAP 417 
strains showing particularly large standard deviations in Figure 1, the efficiency of 418 
the de-clumping step has clearly differed more between the duplicate MAP 419 
suspensions tested for these strains compared to the other MAP strains tested.  The 420 
latter finding suggests that different degrees of de-clumping were being achieved by 421 
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the ultrasonication treatment applied before PMS; thus ultrasonication conditions for 422 
MAP de-clumping purposes may need further optimization. 423 
In relation to specificity, this study assessed if the D29 mycobacteriophage 424 
involved in the phage assay was capable of infecting other Mycobacterium spp., or 425 
other raw milk bacteria, which might potentially lead to formation of plaques in the 426 
absence of MAP when the method is used to test milk samples.  A previous study 427 
carried out by Rybniker et al. (2006) reported that the D29 mycobacteriophage can 428 
infect various Mycobacterium spp. including M. smegmatis, M. tuberculosis, M. bovis 429 
BCG, M. avium, M. scrofulaceum and M. ulcerans, whereas it was unable to infect 430 
M. marinum, M. fortuitum and M. chelonae. The assay used in this study was 431 
modified for MAP based on its specific burst time, which was found to be longer than 432 
for other Mycobacterium spp. (Foddai et al. 2009). As cell lysis is dependent on the 433 
host’s generation time, the D29 phage requires a longer time (220 min) within MAP 434 
cells to replicate and release the new phage progeny than in other faster-growing 435 
Mycobacterium spp.; the burst time of which generally ranges between 1 and 2 436 
hours (David et al. 1980). Consequently, the virucidal treatment applied after two 437 
hours of incubation with D29 bacteriophage would have no detrimental effect against 438 
phage particles still to be released from MAP cells, whereas it inactivates any 439 
progeny phage already released from faster-growing mycobacteria. This explains the 440 
absence of plaques for almost all Mycobacterium spp. tested in this study. Some 441 
plaques were only observed with M. bovis BCG, which is the sole Mycobacterium sp. 442 
tested with a similar burst time to MAP (180 min; Foddai and Grant unpublished 443 
data). However, minimal recovery of M. bovis BCG (<1%) was observed when the 444 
test was applied after PMS, confirming the high specificity (>99%) of the test for MAP 445 
if the optimized phage assay is applied in combination with PMS. Finally, no plaques 446 
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were observed for any of the milk bacteria tested, suggesting no risk of interference 447 
from bacterial species that might be encountered when testing raw milk for MAP. 448 
Detection sensitivity, specifically LOD50, was the last aspect of the PMS-449 
phage assay investigated in the present study. Evidence to date suggests that MAP 450 
is typically present in raw milk in low numbers (Sweeney et al. 1992; Slana et al. 451 
2009). Since conventional culture often does not have sufficient sensitivity (Slana et 452 
al. 2008a), an alternative detection method is required to rapidly demonstrate the 453 
presence of viable MAP in milk and achieve more accurate enumeration. Results 454 
from testing of both artificially and naturally infected milk samples indicate that the 455 
optimised PMS-phage assay possesses the sensitivity needed to detect low levels of 456 
MAP in raw milk.  The optimised PMS-phage assay demonstrated higher sensitivity 457 
than both PMS-culture (on HEYM agar plates) and PMS-qPCR, targeting either 458 
IS900 or f57, when the test was used to test whole milk spiked at different levels with 459 
two MAP strains. Plaques were observed from all the milk samples, including those 460 
originally spiked with 1-10 MAP cells per 50 ml. Higher LOD50 were observed for the 461 
two other PMS-based detection methods (≥ 100 PFU per 50 ml). The higher MAP 462 
detection rates observed with the PMS-phage assay during raw milk testing further 463 
confirmed the higher sensitivity of this test compared to PMS-culture and PMS-464 
qPCR. Viable MAP cells were detected by PMS-phage assay in 21.2% of individual 465 
milk samples and 59.1% of BTM samples tested. These detection rates were 466 
consistently higher than corresponding rates observed for PMS-IS900 qPCR (9.1% 467 
and 45.4%, respectively), PMS-f57qPCR (2.6% and 9.1%, respectively) and PMS-468 
culture (11.6% and 50%, respectively). It should be noted that for raw milk testing 469 
MGIT broth was employed rather than HEYM agar plates for culture after PMS, and 470 
it was noticeable that the detection sensitivity of PMS-culture was much improved, 471 
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compared to the outcomes of LOD50 determinations using spiked milk. From past 472 
experience, liquid culture does tend to be more conducive for MAP growth than solid 473 
culture. The optimised PMS-phage assay proved to be a more sensitive and quicker 474 
alternative to conventional culture for demonstrating the presence of viable MAP in 475 
cows’ milk. 476 
Application of the optimised PMS-phage assay to test naturally infected milks 477 
during this study provided new information on numbers of viable MAP present in milk 478 
from individual animals and BTM from Johne’s affected herds. Mean MAP counts 479 
estimated from individual infected cows and BTM milk were 228 PFU per 50 ml 480 
(range 6-948 PFU per 50 ml) and 144.9 PFU per 50 ml (range 18-685 PFU per 50 481 
ml), respectively. These PMS-phage assay counts are higher than previous 482 
estimates of the numbers of MAP cells in both individual milk samples (2 to 8 CFU 483 
per 50 ml, Sweeney et al. 1992; <100 CFU per ml, Giese and Ahrens 2000; 4 to 20 484 
CFU per 50 ml, Ayele et al. 2005; 10 to 560 cells per ml, Slana et al. 2008b) and 485 
BTM (1 to 9 cells per ml, Slana et al. 2008b and “several tens of cells per ml”, Slana 486 
et al. 2009), which were obtained by either culture after chemical decontamination or 487 
real-time qPCR. 488 
On the basis of the inclusivity, specificity, and sensitivity of the PMS-phage 489 
assay reported here, and its superior performance relative to PMS-qPCR and PMS-490 
culture for testing raw milk samples, the PMS-phage assay represents the most 491 
sensitive test available to detect viable MAP in milk. However, as currently 492 
performed, the PMS-phage assay involves two overnight incubations, multiple timed 493 
steps and additions of reagents, and a plaque PCR to confirm MAP detection; so is 494 
laborious to carry out and it takes 2-3 days to obtain a MAP positive result. Only with 495 
considerable practice in application of the PMS-phage assay over several years 496 
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have consistent results been obtained within our laboratory. Whilst the phage 497 
amplification assay and PMS-phage assay are proving to be valuable MAP research 498 
tools, the PMS-phage assay is not suitable for adoption by the dairy industry as a 499 
milk screening test in its current format.  The assay would require some streamlining, 500 
specifically to eliminate the need for the plaque assay and plaque PCR after phage 501 
amplification, in order to potentially become such a test. Potential avenues to 502 
achieve this goal are currently being explored in our laboratory.  503 
To conclude, this study has demonstrated that the optimised PMS-phage 504 
assay is 100% inclusive for all MAP strains tested, >99% specific for MAP, and has a 505 
LOD50 of ~1 PFU per 50 ml milk. When used in combination with the optimized milk 506 
sample preparation protocol (Foddai and Grant, 2015), the assay detected viable 507 
MAP in raw milk from a substantial proportion (21.2%) of individual cows in a JD 508 
affected dairy herd (mean MAP count 228.1 PFU per 50 ml) and in 59.1% of BTM 509 
from JD affected dairy farms in Scotland (mean MAP count 136.83 PFU per 50 ml). 510 
This study has also demonstrated that the optimised PMS-phage assay is more 511 
sensitive than both PMS-qPCR and PMS-culture (on HEYM or in MGIT liquid 512 
medium). Unfortunately, in its present multi-step format, the PMS-phage assay does 513 
not represent a test that could be easily adopted by the dairy industry for routinely 514 
screening large numbers of milk samples to detect the presence of MAP.  Efforts are 515 
continuing to streamline the assay, whilst maintaining its excellent detection 516 
sensitivity, to make it suitable for that purpose.   517 
 518 
Acknowledgements 519 
The authors would wish to thank Mr Peter Orpin, The Park Veterinary Group, 520 
Leicester, England, and Dr George Caldow, Veterinary Manager, SAC Consulting 521 
22 
 
Veterinary Services, St. Boswells, Scotland, for identifying suitable dairy herds to 522 
sample bulk milk from, as well as the manager of the large UK dairy herd for 523 
facilitating milk collection.   524 
 525 
Conflict of interest  526 
No conflict of interest declared.   527 
 528 
References 529 
AOAC International (2006)  International Presidential Task Force on Best Practices 530 
in Microbiological Methodology Final report and executive summaries. Appendix 531 
K. Proposed use of a 50% limit of detection value in defining uncertainty limits in 532 
the validation of presence-absence microbial detection methods. Available online: 533 
http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-foods-gen/documents/do 534 
cument/ucm088764.pdf (Accessed 14/12/2016). 535 
Ayele, W.Y., Svastova, P., Roubal, P., Bartos, M. and Pavlik, I. (2005) 536 
Mycobacterium avium subspecies paratuberculosis cultured from locally and 537 
commercially pasteurized cow's milk in the Czech Republic. Appl Environ 538 
Microbiol 71, 1210-1214.  539 
Carvalho, I.A., Campos, V.E.B., Souza, I.M., Zanardo, L.G., Ribeiro, J.D., Gomez, 540 
M.J.P. and Moreira, M.A.S. (2012) Diagnosis of paratuberculosis in cattle: 541 
microbiological culture, serology and PCR. Braz J Microbiol 43, 581-585. 542 
David, H.L., Clavel, S. and Clement, F. (1980) Adsorption and growth of the 543 
bacteriophage D29 in selected mycobacteria. Ann Virol 131, 167-184. 544 
23 
 
Donaghy, J.A., Johonson, J. and Rowe, M.T. (2010) Detection of Mycobacterium 545 
avium subsp. paratuberculosis in cheese, milk powder and milk using IS90 and 546 
F57- based assays. J Appl Microbiol 110, 479-489. 547 
Ellingson, J.L., Anderson, J.L., Koziczkowsk, J.J., Radcliff, R.P., Sloan, S.J., Allen, 548 
S.E. and Sullivan, N.M. (2005) Detection of viable Mycobacterium avium subsp. 549 
paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. 550 
J Food Prot 68, 966-972. 551 
Feller, M., Huwiler, K., Stephan, R., Altpeter, E., Shang, A., Furrer, H., Pfyffer, G.E., 552 
Jemmi, T., Baumgartner, A., and Egger, M. (2007) Mycobacterium avium 553 
subspecies paratuberculosis and Crohn's disease: a systematic review and meta-554 
analysis. Lancet Infect Dis 7, 607–613. 555 
Foddai, A., Elliott, C.T. and Grant, I.R. (2009) Optimization of a phage amplification 556 
assay to permit accurate enumeration of viable Mycobacterium avium subsp. 557 
paratuberculosis cells.  Appl Environ Microbiol 75, 3896-3902. 558 
Foddai, A., Elliott, C.T. and Grant, I.R. (2010a) Rapid assessment of the viability of 559 
Mycobacterium avium subsp. paratuberculosis after heating using the optimized 560 
phage amplification assay. Appl  Environ Microbiol 76,1777-1782. 561 
Foddai, A., Elliott, C.T. and Grant, I.R. (2010b) Maximizing capture efficiency and 562 
specificity of magnetic separation for Mycobacterium avium subsp. 563 
paratuberculosis cells. Appl Environ Microbiol 76, 7550-7558. 564 
Foddai, A., Strain, S., Whitlock, R.H., Elliott, C.T. and Grant, I.R. (2011) Application 565 
of a peptide-mediated magnetic separation-phage assay for detection of viable 566 
Mycobacterium avium subsp. paratuberculosis to bovine bulk tank milk and feces 567 
samples. J Clin Microbiol 49, 2017-2019. 568 
24 
 
Foddai, A.C.G. and Grant, I.R. (2015) An optimised milk testing protocol to ensure 569 
accurate enumeration of viable Mycobacterium avium subsp. paratuberculosis by 570 
the PMS-phage assay. Int Dairy J 51, 16-23. 571 
Gao, A., Odumeru, J., Raymond M. and Mutharia, L. (2005) Development of 572 
improved method for isolation of Mycobacterium avium subsp. paratuberculosis 573 
from bulk tank milk: effect of age of milk, centrifugation, and decontamination. Can 574 
J Vet Res 69, 81-87. 575 
Giese, S. and Ahrens, P. (2000) Detection of Mycobacterium avium subsp. 576 
paratuberculosis in milk from clinically affected cows by PCR and culture. Vet 577 
Microbiol 77, 291–297. 578 
Grant, I.R., Ball, H.J. and Rowe, M.T. (2002) Incidence of Mycobacterium 579 
paratuberculosis in bulk raw and commercially pasteurized cows' milk from 580 
approved dairy processing establishments in the United Kingdom. Appl Environ 581 
Microbiol 68, 2428-2435.  582 
Grant, I.R., Kirk, R.B., Hitchings, E. and Rowe, M.T. (2003) Comparative evaluation 583 
of the MGIT and BACTEC culture systems for the recovery of Mycobacterium 584 
avium subsp. paratuberculosis from milk. J  Appl Microbiol 95, 196–201. 585 
Manning, E.J.B. and Collins, M.T. (2001) Mycobacterium avium subsp. 586 
paratuberculosis: pathogen, pathogenity and diagnosis. Rev Sci Tech Off Int Epi 587 
20, 133-150. 588 
Naser, S.A., Thanigachalam, S., Dow, C.T. and Collins, M.T. (2013) Exploring the 589 
role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of 590 
type 1 diabetes mellitus: a pilot study. Gut Path 3, 1-14. 591 
Nielsen, S.S. and Toft, N. (2009) A review of prevalence of paratuberculosis in 592 
farmed animals in Europe. Prev Vet Med 88, 1-14. 593 
25 
 
NordVal / NMKL (2009) Protocol for the validation of alternative microbiological 594 
methods.  http://www.nmkl.org/dokumenter/nordval/NordValProtocol.pdf 595 
(Accessed 14/12/2016). 596 
Paolicchi, F., Cirone, K., Morsella, C. and Gioffre, A. (2012) First isolation of 597 
Mycobacterium avium subsp. paratuberculosis from commercial pasteurized milk 598 
in Argentina. Braz J Microbiol 43, 1034-1037. 599 
Rybniker, J., Kramme, S. and Small, P.L. (2006) Host range of 14 600 
mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria 601 
including Mycobacterium tuberculosis – application for identification and 602 
susceptibility testing. J Med Microbiol 55, 37-42. 603 
Slana, I., Paolicchi, F., Janstova, B., Navratilova, P. and Pavlik, I. (2008a) Detection 604 
methods for Mycobacterium avium subsp. paratuberculsosis in milk and milk 605 
products: a review. Vet Med Czech 53, 2283-306. 606 
Slana, I., Kralik, P., Kralova, A. and Pavlik, I. (2008b) On-farm spread of 607 
Mycobacterium avium subsp. paratuberculosis in raw milk studied by IS900 and 608 
F57 competitive real time quantitative PCR and culture examination. Int J Food 609 
Microbiol 128, 250–257. 610 
Slana, I., Liapi, M., Moravkova, M., Kralova, A. and Pavlik, I. (2009) Mycobacterium 611 
avium subsp. paratuberculosis in cow bulk tank milk in Cyprus detected by culture 612 
and quantitative IS900 and F57 real-time PCR.  Prev Vet Med 89, 223-226. 613 
Stabel, J. (1998) Johne’s disease: a hidden threat. J Dairy Sci 81, 283-288. 614 
Stanley, E.C., Mole, R.J., Smith, R.J., Glenn, S.M., Barer, M.R., McGowan, M. and 615 
Rees, C.E.D. (2007) Development of a new, combined rapid method using phage 616 
and PCR for detection and identification of viable Mycobacterium paratuberculosis 617 
bacteria within 48 Hours. Appl Environ Microbiol 73, 1851–1857. 618 
26 
 
Sweeney, R.W., Whitlock, R.H. and Rosenberger, A.E. (1992) Mycobacterium 619 
paratuberculosis cultured from milk and supramammary lymph nodes of infected 620 
asymptomatic cows. J Clin Microbiol 30, 166–171. 621 
Swift, B.M.C., Denton, E.J., Mahendran, S.A., Huxley, J.N. and Rees, C.E.D. (2013) 622 
Development of a rapid phage-based method for the detection of viable 623 
Mycobacterium avium subsp, paratuberculosis in blood within 48 h. J Microbiol 624 
Meth 94, 175-179. 625 
Timms, V.J., Gehringer, M.M., Mitchel, H.L., Daskalopoulos, M.G. and Neilan, B.A. 626 
(2011) How accurately can we detect Mycobacterium avium subsp. 627 
paratuberculosis  infection. J  Microbiol Meth 85, 1-8. 628 
Timms, V.J., Hazel, M.M. and Neilan, B.A. (2015) Optimization of DNA extraction 629 
and validation of PCR assays to detect Mycobacterium avium subsp. 630 
paratuberculsosis. J Microbiol Meth 112, 99-103. 631 
Timms, V.L., Daskalopoulos, G., Mitchell, H.M. and Neilan, B.A. (2016) The 632 
association of Mycobacterium avium subsp. paratuberculosis with inflammatory 633 
bowel disease. PLoS ONE 11, e0148731. 634 
Tiwari, A., Van Leeuwen, J.A., Mckenna, S.L.B., Keefe, G.P. and Barkema, H.V. 635 
(2006) Johne's disease in Canada. Part 1: Clinical symptoms, pathophysiology, 636 
diagnosis, and prevalence in dairy herds. Can Vet J 47, 874-882. 637 
Waddel, L.A., Rajic, A., Stark, K.D.C. and McEwen S.A. (2015) The zoonotic 638 
potential of Mycobacterium avium ssp. paratuberculosis: a systematic review and 639 
meta-analyses of the evidence. Epid Infect 143, 3135-3157. 640 
Wilson, D.J., Rood, K., Biswas, P. and Byrem, T.M. (2010) Herd-level prevalence of 641 
Johne's disease in Utah and adjacent areas of the Intermountain West as 642 
detected by a bulk-tank milk surveillance project. J Dairy Sci 93, 5792-5797 643 
27 
 
Table 1.  Details of Mycobacterium spp. tested to confirm specificity of the PMS-644 
phage assay. 645 
Test Mycobacterium sp. Strain ID or Source 
M. avium subsp. avium  AFBIa 
M. avium subsp. avium NCTCb 13034 
M. bovis BCG  NCTC 5692 
M. fortuitum  NCTC 10394 
M. gordonae NCTC 10267 
M. intracellulare NCTC 10425 
M. kansasii NCTC 10268 
M. marinum  AFBI 
M. scrofulaceum AFBI 
M. smegmatis  mc2 155c 
M. terrae AFBI 
M. xenopi AFBI 
a Culture kindly provided by Dr Lyanne McCallan, Veterinary Sciences Division, Agri-646 
Food and Biosciences Institute (AFBI) for Northern Ireland, Belfast, UK. No other 647 
strain information available. 648 
b Purchased from National Collection of Type Cultures, Colindale, London. 649 
c Originally provided by Dr Ruth McNerney, London School of Hygiene and Tropical 650 
Medicine.   651 
 652 
 653 
.654 
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Table 2.  Comparison of limits of detection 50% (LOD50) of the different PMS-based assays.  Data represent number of samples 655 
test positive of total number of samples tested at each spiking level.  656 
 657 
MAP strain Test Spiking level (PFU per 50 ml milk) LOD50 (95% CI) 
102-103 101-102 1-101 Non-spiked 
NCTC 8578 PMS-phage assay 3/3 3/3 3/3 0/3 0.90 * 
 PMS-IS900 qPCR 3/3 1/3 0/3 0/3 136.70 (21.40-872.90) 
 PMS-f57 qPCR 3/3 0/3 0/3 0/3 303.70 * 
 PMS-HEYM culture 0/3 0/3 0/3 0/3 - ǂ 
       
ATCC 19698 PMS-phage assay 3/3 3/3 3/3 0/3 0.95 * 
 PMS-IS900 qPCR 3/3 1/3 0/3 0/3 134.55 (23.45-772.80) 
 PMS-f57 qPCR 3/3 0/3 0/3 0/3 291.00 * 
 PMS-HEYM culture 0/3 0/3 0/3 0/3 - 
* LOD50 could not be calculated because no spiking level yielded a partially positive response, i.e. <3/3 658 
ǂ LOD50 could not be calculated because no milk sample at highest spiking level tested positive after PMS-culture. 659 
660 
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Table 3.  Number of MAP positive individual raw milk and bulk tank milk samples obtained by three PMS-based methods – 661 
optimised PMS-phage assay, PMS-qPCR (targeting both IS900 and F57) and PMS-culture in MGIT broth supplemented with 662 
PANTA and mycobactin J. 663 
 
 
Type of milk sample 
PMS-phage  
assay* 
 PMS-qPCR   PMS-MGIT culture †  
 IS900  F57    
No. 
tested 
No. 
Pos 
%  
Pos 
 No. 
testedǂ 
No. 
Pos 
% 
Pos 
 No. 
tested 
No. 
Pos 
% 
Pos 
  No. 
tested 
No. 
Pos** 
% 
Pos 
 
Individual raw milk  
 
146 31 21.2  77 7 9.1  77 2 2.6   146 17 11.6 
Bulk tank milk 
 
22 13 59.1  22 10 45.4  22 2 9.1   22 11 50 
* Only reported PMS-phage assay positive when DNA harvested from plaques tested Plaque-PCR positive. 664 
† Only reported PMS-culture positive if presence of MAP confirmed by IS900 PCR applied to broth culture. 665 
ǂ All 146 individual milk samples were not tested by either PMS-qPCR assay due to cost constraints. The 77 samples tested 666 
included 47 samples that had yielded plaques with the PMS-phage assay plus 30 other randomly selected PMS-phage assay 667 
negative samples.  668 
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Figure 1. Inclusivity of the optimised PMS-phage assay demonstrated by testing 43 669 
different MAP strains, and variation in plaque counts obtained for duplicate tests on 670 
each strain.  Data represent mean plaque count +/- standard deviation. 671 
 672 
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Figure 2. Venn diagrams showing inter-relationships between optimised PMS-phage 673 
assay, PMS-culture and PMS-IS900 qPCR results for individual raw milk samples (A 674 
and B) and BTM samples (C). An asterisk indicates that the corresponding PMS-675 
phage assay yielded plaques but presence of MAP DNA was not confirmed by 676 
plaque-PCR, and so PMS-phage assay result was recorded as negative.   677 
 678 
